A Randomized Controlled Trial of the Group-Based Modified Story Memory Technique in TBI
Abstract
Impairments in new learning and memory are among the most common deficits in individuals with Traumatic Brain Injury (TBI) and have been shown to exert significant negative impact on everyday life. There is thus a tremendous need for the development of effective interventions for learning and memory dysfunction in TBI, particularly group-based interventions for which 3rd party payment may be more forthcoming. The current study addresses this critical need through the conduct of a double blind, placebo-controlled, randomized clinical trial (RCT) of a group administration of the modified Story Memory Technique (mSMT). Over a decade of research and development conducted at our center has demonstrated the mSMT to be effective for improving new learning and memory in individuals with Multiple Sclerosis (MS) and TBI across three realms of functioning, objective behavior, brain functioning and everyday life. This convincing data provides Class I evidence supporting the efficacy of the mSMT for improving new learning and memory in these populations. Given the strong efficacy data on the mSMT, coupled with the current trends in insurance reimbursement, clinicians worldwide have highlighted the need to provide the mSMT via an effective group format. We have thus modified the treatment protocol for group administration. This pilot RCT tests the efficacy of a group administration of the mSMT for persons with moderate to severe TBI.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2022
- Accession Number
- AD1189867
Entities
People
- Nancy D. Chiaravalloti